Global Antimycobacterial Drugs Market 2018 by Manufacturers, Countries, Type and Application, Forecast to 2023

October 2018 | 119 pages | ID: G4D9C185A5CGEN
GlobalInfoResearch

Abstracts

Antimycobacterial drugs are used to treat infections caused by members of Mycobacterium genus. Mycobacterium genus includes M. tuberculosis, M. leprae, and M. avium-intracellulare which cause tuberculosis, leprosy, and atypical mycobacteria, respectively.

SCOPE OF THE REPORT:

The hospital pharmacies segment dominated the antimycobacterial drugs market in 2017 due to easy availability of leprosy and tuberculosis medications in government hospitals. The segment is expected to continue to dominate the market from 2018 to 2025.
The global Antimycobacterial Drugs market is valued at xx million USD in 2017 and is expected to reach xx million USD by the end of 2023, growing at a CAGR of xx% between 2017 and 2023.
The Asia-Pacific will occupy for more market share in following years, especially in China, also fast growing India and Southeast Asia regions.
North America, especially The United States, will still play an important role which cannot be ignored. Any changes from United States might affect the development trend of Antimycobacterial Drugs.
Europe also play important roles in global market, with market size of xx million USD in 2017 and will be xx million USD in 2023, with a CAGR of xx%.
This report studies the Antimycobacterial Drugs market status and outlook of Global and major regions, from angles of players, countries, product types and end industries; this report analyzes the top players in global market, and splits the Antimycobacterial Drugs market by product type and applications/end industries.
Market Segment by Companies, this report covers

• Pfizer
• Novartis
• GlaxoSmithKline
• Bayer
• AstraZeneca
• Sanofi
• Merck
• Lupin
• Macleods Pharmaceuticals
• Systopic Laboratories
• Zydus Cadila

Market Segment by Regions, regional analysis covers

• North America (United States, Canada and Mexico)
• Europe (Germany, France, UK, Russia and Italy)
• Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
• South America (Brazil, Argentina, Colombia)
• Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)

Market Segment by Type, covers

• Drugs Used for Tuberculosis
• Drugs Used for Leprosy
• Drugs Used for Atypical Mycobacteria

Market Segment by Applications, can be divided into

• Hospital Pharmacies
• Retail Pharmacies
• Online Pharmacies

Contents

1 ANTIMYCOBACTERIAL DRUGS MARKET OVERVIEW

1.1 Product Overview and Scope of Antimycobacterial Drugs
1.2 Classification of Antimycobacterial Drugs by Types
  1.2.1 Global Antimycobacterial Drugs Revenue Comparison by Types (2017-2023)
  1.2.2 Global Antimycobacterial Drugs Revenue Market Share by Types in 2017
  1.2.3 Drugs Used for Tuberculosis
  1.2.4 Drugs Used for Leprosy
  1.2.5 Drugs Used for Atypical Mycobacteria
1.3 Global Antimycobacterial Drugs Market by Application
  1.3.1 Global Antimycobacterial Drugs Market Size and Market Share Comparison by Applications (2013-2023)
  1.3.2 Hospital Pharmacies
  1.3.3 Retail Pharmacies
  1.3.4 Online Pharmacies
1.4 Global Antimycobacterial Drugs Market by Regions
  1.4.1 Global Antimycobacterial Drugs Market Size (Million USD) Comparison by Regions (2013-2023)
  1.4.1 North America (USA, Canada and Mexico) Antimycobacterial Drugs Status and Prospect (2013-2023)
  1.4.2 Europe (Germany, France, UK, Russia and Italy) Antimycobacterial Drugs Status and Prospect (2013-2023)
  1.4.3 Asia-Pacific (China, Japan, Korea, India and Southeast Asia) Antimycobacterial Drugs Status and Prospect (2013-2023)
  1.4.4 South America (Brazil, Argentina, Colombia) Antimycobacterial Drugs Status and Prospect (2013-2023)
  1.4.5 Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa) Antimycobacterial Drugs Status and Prospect (2013-2023)
1.5 Global Market Size of Antimycobacterial Drugs (2013-2023)

2 MANUFACTURERS PROFILES

2.1 Pfizer
  2.1.1 Business Overview
  2.1.2 Antimycobacterial Drugs Type and Applications
    2.1.2.1 Product A
    2.1.2.2 Product B
  2.1.3 Pfizer Antimycobacterial Drugs Revenue, Gross Margin and Market Share (2016-2017)
2.2 Novartis
  2.2.1 Business Overview
  2.2.2 Antimycobacterial Drugs Type and Applications
    2.2.2.1 Product A
    2.2.2.2 Product B
  2.2.3 Novartis Antimycobacterial Drugs Revenue, Gross Margin and Market Share (2016-2017)
2.3 GlaxoSmithKline
  2.3.1 Business Overview
  2.3.2 Antimycobacterial Drugs Type and Applications
    2.3.2.1 Product A
    2.3.2.2 Product B
  2.3.3 GlaxoSmithKline Antimycobacterial Drugs Revenue, Gross Margin and Market Share (2016-2017)
2.4 Bayer
  2.4.1 Business Overview
  2.4.2 Antimycobacterial Drugs Type and Applications
    2.4.2.1 Product A
    2.4.2.2 Product B
  2.4.3 Bayer Antimycobacterial Drugs Revenue, Gross Margin and Market Share (2016-2017)
2.5 AstraZeneca
  2.5.1 Business Overview
  2.5.2 Antimycobacterial Drugs Type and Applications
    2.5.2.1 Product A
    2.5.2.2 Product B
  2.5.3 AstraZeneca Antimycobacterial Drugs Revenue, Gross Margin and Market Share (2016-2017)
2.6 Sanofi
  2.6.1 Business Overview
  2.6.2 Antimycobacterial Drugs Type and Applications
    2.6.2.1 Product A
    2.6.2.2 Product B
  2.6.3 Sanofi Antimycobacterial Drugs Revenue, Gross Margin and Market Share (2016-2017)
2.7 Merck
  2.7.1 Business Overview
  2.7.2 Antimycobacterial Drugs Type and Applications
    2.7.2.1 Product A
    2.7.2.2 Product B
  2.7.3 Merck Antimycobacterial Drugs Revenue, Gross Margin and Market Share (2016-2017)
2.8 Lupin
  2.8.1 Business Overview
  2.8.2 Antimycobacterial Drugs Type and Applications
    2.8.2.1 Product A
    2.8.2.2 Product B
  2.8.3 Lupin Antimycobacterial Drugs Revenue, Gross Margin and Market Share (2016-2017)
2.9 Macleods Pharmaceuticals
  2.9.1 Business Overview
  2.9.2 Antimycobacterial Drugs Type and Applications
    2.9.2.1 Product A
    2.9.2.2 Product B
  2.9.3 Macleods Pharmaceuticals Antimycobacterial Drugs Revenue, Gross Margin and Market Share (2016-2017)
2.10 Systopic Laboratories
  2.10.1 Business Overview
  2.10.2 Antimycobacterial Drugs Type and Applications
    2.10.2.1 Product A
    2.10.2.2 Product B
  2.10.3 Systopic Laboratories Antimycobacterial Drugs Revenue, Gross Margin and Market Share (2016-2017)
2.11 Zydus Cadila
  2.11.1 Business Overview
  2.11.2 Antimycobacterial Drugs Type and Applications
    2.11.2.1 Product A
    2.11.2.2 Product B
  2.11.3 Zydus Cadila Antimycobacterial Drugs Revenue, Gross Margin and Market Share (2016-2017)

3 GLOBAL ANTIMYCOBACTERIAL DRUGS MARKET COMPETITION, BY PLAYERS

3.1 Global Antimycobacterial Drugs Revenue and Share by Players (2013-2018)
3.2 Market Concentration Rate
  3.2.1 Top 5 Antimycobacterial Drugs Players Market Share
  3.2.2 Top 10 Antimycobacterial Drugs Players Market Share
3.3 Market Competition Trend

4 GLOBAL ANTIMYCOBACTERIAL DRUGS MARKET SIZE BY REGIONS

4.1 Global Antimycobacterial Drugs Revenue and Market Share by Regions
4.2 North America Antimycobacterial Drugs Revenue and Growth Rate (2013-2018)
4.3 Europe Antimycobacterial Drugs Revenue and Growth Rate (2013-2018)
4.4 Asia-Pacific Antimycobacterial Drugs Revenue and Growth Rate (2013-2018)
4.5 South America Antimycobacterial Drugs Revenue and Growth Rate (2013-2018)
4.6 Middle East and Africa Antimycobacterial Drugs Revenue and Growth Rate (2013-2018)

5 NORTH AMERICA ANTIMYCOBACTERIAL DRUGS REVENUE BY COUNTRIES

5.1 North America Antimycobacterial Drugs Revenue by Countries (2013-2018)
5.2 USA Antimycobacterial Drugs Revenue and Growth Rate (2013-2018)
5.3 Canada Antimycobacterial Drugs Revenue and Growth Rate (2013-2018)
5.4 Mexico Antimycobacterial Drugs Revenue and Growth Rate (2013-2018)

6 EUROPE ANTIMYCOBACTERIAL DRUGS REVENUE BY COUNTRIES

6.1 Europe Antimycobacterial Drugs Revenue by Countries (2013-2018)
6.2 Germany Antimycobacterial Drugs Revenue and Growth Rate (2013-2018)
6.3 UK Antimycobacterial Drugs Revenue and Growth Rate (2013-2018)
6.4 France Antimycobacterial Drugs Revenue and Growth Rate (2013-2018)
6.5 Russia Antimycobacterial Drugs Revenue and Growth Rate (2013-2018)
6.6 Italy Antimycobacterial Drugs Revenue and Growth Rate (2013-2018)

7 ASIA-PACIFIC ANTIMYCOBACTERIAL DRUGS REVENUE BY COUNTRIES

7.1 Asia-Pacific Antimycobacterial Drugs Revenue by Countries (2013-2018)
7.2 China Antimycobacterial Drugs Revenue and Growth Rate (2013-2018)
7.3 Japan Antimycobacterial Drugs Revenue and Growth Rate (2013-2018)
7.4 Korea Antimycobacterial Drugs Revenue and Growth Rate (2013-2018)
7.5 India Antimycobacterial Drugs Revenue and Growth Rate (2013-2018)
7.6 Southeast Asia Antimycobacterial Drugs Revenue and Growth Rate (2013-2018)

8 SOUTH AMERICA ANTIMYCOBACTERIAL DRUGS REVENUE BY COUNTRIES

8.1 South America Antimycobacterial Drugs Revenue by Countries (2013-2018)
8.2 Brazil Antimycobacterial Drugs Revenue and Growth Rate (2013-2018)
8.3 Argentina Antimycobacterial Drugs Revenue and Growth Rate (2013-2018)
8.4 Colombia Antimycobacterial Drugs Revenue and Growth Rate (2013-2018)

9 MIDDLE EAST AND AFRICA REVENUE ANTIMYCOBACTERIAL DRUGS BY COUNTRIES

9.1 Middle East and Africa Antimycobacterial Drugs Revenue by Countries (2013-2018)
9.2 Saudi Arabia Antimycobacterial Drugs Revenue and Growth Rate (2013-2018)
9.3 UAE Antimycobacterial Drugs Revenue and Growth Rate (2013-2018)
9.4 Egypt Antimycobacterial Drugs Revenue and Growth Rate (2013-2018)
9.5 Nigeria Antimycobacterial Drugs Revenue and Growth Rate (2013-2018)
9.6 South Africa Antimycobacterial Drugs Revenue and Growth Rate (2013-2018)

10 GLOBAL ANTIMYCOBACTERIAL DRUGS MARKET SEGMENT BY TYPE

10.1 Global Antimycobacterial Drugs Revenue and Market Share by Type (2013-2018)
10.2 Global Antimycobacterial Drugs Market Forecast by Type (2018-2023)
10.3 Drugs Used for Tuberculosis Revenue Growth Rate (2013-2023)
10.4 Drugs Used for Leprosy Revenue Growth Rate (2013-2023)
10.5 Drugs Used for Atypical Mycobacteria Revenue Growth Rate (2013-2023)

11 GLOBAL ANTIMYCOBACTERIAL DRUGS MARKET SEGMENT BY APPLICATION

11.1 Global Antimycobacterial Drugs Revenue Market Share by Application (2013-2018)
11.2 Antimycobacterial Drugs Market Forecast by Application (2018-2023)
11.3 Hospital Pharmacies Revenue Growth (2013-2018)
11.4 Retail Pharmacies Revenue Growth (2013-2018)
11.5 Online Pharmacies Revenue Growth (2013-2018)

12 GLOBAL ANTIMYCOBACTERIAL DRUGS MARKET SIZE FORECAST (2018-2023)

12.1 Global Antimycobacterial Drugs Market Size Forecast (2018-2023)
12.2 Global Antimycobacterial Drugs Market Forecast by Regions (2018-2023)
12.3 North America Antimycobacterial Drugs Revenue Market Forecast (2018-2023)
12.4 Europe Antimycobacterial Drugs Revenue Market Forecast (2018-2023)
12.5 Asia-Pacific Antimycobacterial Drugs Revenue Market Forecast (2018-2023)
12.6 South America Antimycobacterial Drugs Revenue Market Forecast (2018-2023)
12.7 Middle East and Africa Antimycobacterial Drugs Revenue Market Forecast (2018-2023)

13 RESEARCH FINDINGS AND CONCLUSION

14 APPENDIX

14.1 Methodology
14.2 Data Source

List Of Tables

LIST OF TABLES AND FIGURES

Figure Antimycobacterial Drugs Picture
Table Product Specifications of Antimycobacterial Drugs
Table Global Antimycobacterial Drugs and Revenue (Million USD) Market Split by Product Type
Figure Global Antimycobacterial Drugs Revenue Market Share by Types in 2017
Figure Drugs Used for Tuberculosis Picture
Figure Drugs Used for Leprosy Picture
Figure Drugs Used for Atypical Mycobacteria Picture
Table Global Antimycobacterial Drugs Revenue (Million USD) by Application (2013-2023)
Figure Antimycobacterial Drugs Revenue Market Share by Applications in 2017
Figure Hospital Pharmacies Picture
Figure Retail Pharmacies Picture
Figure Online Pharmacies Picture
Table Global Market Antimycobacterial Drugs Revenue (Million USD) Comparison by Regions 2013-2023
Figure North America Antimycobacterial Drugs Revenue (Million USD) and Growth Rate (2013-2023)
Figure Europe Antimycobacterial Drugs Revenue (Million USD) and Growth Rate (2013-2023)
Figure Asia-Pacific Antimycobacterial Drugs Revenue (Million USD) and Growth Rate (2013-2023)
Figure South America Antimycobacterial Drugs Revenue (Million USD) and Growth Rate (2013-2023)
Figure Middle East and Africa Antimycobacterial Drugs Revenue (Million USD) and Growth Rate (2013-2023)
Figure Global Antimycobacterial Drugs Revenue (Million USD) and Growth Rate (2013-2023)
Table Pfizer Basic Information, Manufacturing Base and Competitors
Table Pfizer Antimycobacterial Drugs Type and Applications
Table Pfizer Antimycobacterial Drugs Revenue, Gross Margin and Market Share (2016-2017)
Table Novartis Basic Information, Manufacturing Base and Competitors
Table Novartis Antimycobacterial Drugs Type and Applications
Table Novartis Antimycobacterial Drugs Revenue, Gross Margin and Market Share (2016-2017)
Table GlaxoSmithKline Basic Information, Manufacturing Base and Competitors
Table GlaxoSmithKline Antimycobacterial Drugs Type and Applications
Table GlaxoSmithKline Antimycobacterial Drugs Revenue, Gross Margin and Market Share (2016-2017)
Table Bayer Basic Information, Manufacturing Base and Competitors
Table Bayer Antimycobacterial Drugs Type and Applications
Table Bayer Antimycobacterial Drugs Revenue, Gross Margin and Market Share (2016-2017)
Table AstraZeneca Basic Information, Manufacturing Base and Competitors
Table AstraZeneca Antimycobacterial Drugs Type and Applications
Table AstraZeneca Antimycobacterial Drugs Revenue, Gross Margin and Market Share (2016-2017)
Table Sanofi Basic Information, Manufacturing Base and Competitors
Table Sanofi Antimycobacterial Drugs Type and Applications
Table Sanofi Antimycobacterial Drugs Revenue, Gross Margin and Market Share (2016-2017)
Table Merck Basic Information, Manufacturing Base and Competitors
Table Merck Antimycobacterial Drugs Type and Applications
Table Merck Antimycobacterial Drugs Revenue, Gross Margin and Market Share (2016-2017)
Table Lupin Basic Information, Manufacturing Base and Competitors
Table Lupin Antimycobacterial Drugs Type and Applications
Table Lupin Antimycobacterial Drugs Revenue, Gross Margin and Market Share (2016-2017)
Table Macleods Pharmaceuticals Basic Information, Manufacturing Base and Competitors
Table Macleods Pharmaceuticals Antimycobacterial Drugs Type and Applications
Table Macleods Pharmaceuticals Antimycobacterial Drugs Revenue, Gross Margin and Market Share (2016-2017)
Table Systopic Laboratories Basic Information, Manufacturing Base and Competitors
Table Systopic Laboratories Antimycobacterial Drugs Type and Applications
Table Systopic Laboratories Antimycobacterial Drugs Revenue, Gross Margin and Market Share (2016-2017)
Table Zydus Cadila Basic Information, Manufacturing Base and Competitors
Table Zydus Cadila Antimycobacterial Drugs Type and Applications
Table Zydus Cadila Antimycobacterial Drugs Revenue, Gross Margin and Market Share (2016-2017)
Table Global Antimycobacterial Drugs Revenue (Million USD) by Players (2013-2018)
Table Global Antimycobacterial Drugs Revenue Share by Players (2013-2018)
Figure Global Antimycobacterial Drugs Revenue Share by Players in 2016
Figure Global Antimycobacterial Drugs Revenue Share by Players in 2017
Figure Global Top 5 Players Antimycobacterial Drugs Revenue Market Share in 2017
Figure Global Top 10 Players Antimycobacterial Drugs Revenue Market Share in 2017
Figure Global Antimycobacterial Drugs Revenue (Million USD) and Growth Rate (%) (2013-2018)
Table Global Antimycobacterial Drugs Revenue (Million USD) by Regions (2013-2018)
Table Global Antimycobacterial Drugs Revenue Market Share by Regions (2013-2018)
Figure Global Antimycobacterial Drugs Revenue Market Share by Regions (2013-2018)
Figure Global Antimycobacterial Drugs Revenue Market Share by Regions in 2017
Figure North America Antimycobacterial Drugs Revenue and Growth Rate (2013-2018)
Figure Europe Antimycobacterial Drugs Revenue and Growth Rate (2013-2018)
Figure Asia-Pacific Antimycobacterial Drugs Revenue and Growth Rate (2013-2018)
Figure South America Antimycobacterial Drugs Revenue and Growth Rate (2013-2018)
Figure Middle East and Africa Antimycobacterial Drugs Revenue and Growth Rate (2013-2018)
Table North America Antimycobacterial Drugs Revenue by Countries (2013-2018)
Table North America Antimycobacterial Drugs Revenue Market Share by Countries (2013-2018)
Figure North America Antimycobacterial Drugs Revenue Market Share by Countries (2013-2018)
Figure North America Antimycobacterial Drugs Revenue Market Share by Countries in 2017
Figure USA Antimycobacterial Drugs Revenue and Growth Rate (2013-2018)
Figure Canada Antimycobacterial Drugs Revenue and Growth Rate (2013-2018)
Figure Mexico Antimycobacterial Drugs Revenue and Growth Rate (2013-2018)
Table Europe Antimycobacterial Drugs Revenue (Million USD) by Countries (2013-2018)
Figure Europe Antimycobacterial Drugs Revenue Market Share by Countries (2013-2018)
Figure Europe Antimycobacterial Drugs Revenue Market Share by Countries in 2017
Figure Germany Antimycobacterial Drugs Revenue and Growth Rate (2013-2018)
Figure UK Antimycobacterial Drugs Revenue and Growth Rate (2013-2018)
Figure France Antimycobacterial Drugs Revenue and Growth Rate (2013-2018)
Figure Russia Antimycobacterial Drugs Revenue and Growth Rate (2013-2018)
Figure Italy Antimycobacterial Drugs Revenue and Growth Rate (2013-2018)
Table Asia-Pacific Antimycobacterial Drugs Revenue (Million USD) by Countries (2013-2018)
Figure Asia-Pacific Antimycobacterial Drugs Revenue Market Share by Countries (2013-2018)
Figure Asia-Pacific Antimycobacterial Drugs Revenue Market Share by Countries in 2017
Figure China Antimycobacterial Drugs Revenue and Growth Rate (2013-2018)
Figure Japan Antimycobacterial Drugs Revenue and Growth Rate (2013-2018)
Figure Korea Antimycobacterial Drugs Revenue and Growth Rate (2013-2018)
Figure India Antimycobacterial Drugs Revenue and Growth Rate (2013-2018)
Figure Southeast Asia Antimycobacterial Drugs Revenue and Growth Rate (2013-2018)
Table South America Antimycobacterial Drugs Revenue by Countries (2013-2018)
Table South America Antimycobacterial Drugs Revenue Market Share by Countries (2013-2018)
Figure South America Antimycobacterial Drugs Revenue Market Share by Countries (2013-2018)
Figure South America Antimycobacterial Drugs Revenue Market Share by Countries in 2017
Figure Brazil Antimycobacterial Drugs Revenue and Growth Rate (2013-2018)
Figure Argentina Antimycobacterial Drugs Revenue and Growth Rate (2013-2018)
Figure Colombia Antimycobacterial Drugs Revenue and Growth Rate (2013-2018)
Table Middle East and Africa Antimycobacterial Drugs Revenue (Million USD) by Countries (2013-2018)
Table Middle East and Africa Antimycobacterial Drugs Revenue Market Share by Countries (2013-2018)
Figure Middle East and Africa Antimycobacterial Drugs Revenue Market Share by Countries (2013-2018)
Figure Middle East and Africa Antimycobacterial Drugs Revenue Market Share by Countries in 2017
Figure Saudi Arabia Antimycobacterial Drugs Revenue and Growth Rate (2013-2018)
Figure UAE Antimycobacterial Drugs Revenue and Growth Rate (2013-2018)
Figure Egypt Antimycobacterial Drugs Revenue and Growth Rate (2013-2018)
Figure Nigeria Antimycobacterial Drugs Revenue and Growth Rate (2013-2018)
Figure South Africa Antimycobacterial Drugs Revenue and Growth Rate (2013-2018)
Table Global Antimycobacterial Drugs Revenue (Million USD) by Type (2013-2018)
Table Global Antimycobacterial Drugs Revenue Share by Type (2013-2018)
Figure Global Antimycobacterial Drugs Revenue Share by Type (2013-2018)
Figure Global Antimycobacterial Drugs Revenue Share by Type in 2017
Table Global Antimycobacterial Drugs Revenue Forecast by Type (2018-2023)
Figure Global Antimycobacterial Drugs Market Share Forecast by Type (2018-2023)
Figure Global Drugs Used for Tuberculosis Revenue Growth Rate (2013-2018)
Figure Global Drugs Used for Leprosy Revenue Growth Rate (2013-2018)
Figure Global Drugs Used for Atypical Mycobacteria Revenue Growth Rate (2013-2018)
Table Global Antimycobacterial Drugs Revenue by Application (2013-2018)
Table Global Antimycobacterial Drugs Revenue Share by Application (2013-2018)
Figure Global Antimycobacterial Drugs Revenue Share by Application (2013-2018)
Figure Global Antimycobacterial Drugs Revenue Share by Application in 2017
Table Global Antimycobacterial Drugs Revenue Forecast by Application (2018-2023)
Figure Global Antimycobacterial Drugs Market Share Forecast by Application (2018-2023)
Figure Global Hospital Pharmacies Revenue Growth Rate (2013-2018)
Figure Global Retail Pharmacies Revenue Growth Rate (2013-2018)
Figure Global Online Pharmacies Revenue Growth Rate (2013-2018)
Figure Global Antimycobacterial Drugs Revenue (Million USD) and Growth Rate Forecast (2018 -2023)
Table Global Antimycobacterial Drugs Revenue (Million USD) Forecast by Regions (2018-2023)
Figure Global Antimycobacterial Drugs Revenue Market Share Forecast by Regions (2018-2023)
Figure North America Antimycobacterial Drugs Revenue Market Forecast (2018-2023)
Figure Europe Antimycobacterial Drugs Revenue Market Forecast (2018-2023)
Figure Asia-Pacific Antimycobacterial Drugs Revenue Market Forecast (2018-2023)
Figure South America Antimycobacterial Drugs Revenue Market Forecast (2018-2023)
Figure Middle East and Africa Antimycobacterial Drugs Revenue Market Forecast (2018-2023)